Aiosyn, a software company that develops AI-powered pathology solutions, has announced the latest advancement in its automated quality control (QC) algorithm. Aiosyn’s QC solution, AiosynQC, is now fully compatible with immunohistochemistry (IHC) slides, in addition to haematoxylin and eosin (H&E) slides.
This update extends the benefits of AiosynQC and allows laboratories that rely significantly on IHC staining to further streamline operations. “Immunohistochemistry is an integral part of modern pathology practices, and we are excited to offer an AI-powered solution for QC compatible with IHC staining, empowering laboratories to further improve their pathology workflow” says David Tellez, Chief Technology Officer of Aiosyn.
AiosynQC automatically recognises and flags the most common artefacts in histopathology slide images, improving the quality and speed of the digital pathology workflow. The solution helps laboratories to ensure that only high-quality images are utilised by pathologists, scientists and researchers. With the ability to flag problematic cases before they reach the pathologist, AiosynQC improves the efficiency of the workflow by reducing the manual check for artefacts during the quality control of slides. The example pictured above shows unreadable regions affected by air bubbles on an IHC-stained slide image, which have been identified and highlighted with Aiosyn's automated quality control solution powered by AI.
Immunohistochemistry is the second most common staining technique in cellular pathology laboratories after H&E and plays an important role in routine diagnostic work as well as in basic and clinical research, including biomarker exploration. Therefore, the compatibility with such staining marks a significant milestone that highlights Aiosyn's commitment to facilitate the adoption and integration of its software solutions into existing digital pathology workflows.
Alongside the expansion of support for IHC slides, Aiosyn is actively developing advanced deep learning algorithms for various pathologies. The recent launch of AiosynQC on Sectra Amplifier Marketplace further showcases Aiosyn’s dedication to making AI-powered technology accessible to pathology laboratories worldwide.
